SCHEMBL3687811

SCHEMBL3687811

CCCCCCCCCC/C=C/C=C\C=C\C=C\C=C\O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.59
TSHR P16473 1/20 0.59
FASN P49327 1/20 0.57
FAAH O00519 4/20 0.47
KDM4E B2RXH2 1/20 0.47
TRPV1 Q8NER1 1/20 0.46
TERT O14746 2/20 0.45
GMNN O75496 1/20 0.45
USP2 O75604 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
ALOX15 P16050 1/20 0.45
APEX1 P27695 1/20 0.45
CYP2C19 P33261 1/20 0.45
RECQL P46063 1/20 0.45
BLM P54132 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6297582 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E
SCHEMBL16986053 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E
SCHEMBL1806494 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E
SCHEMBL1806493 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E
SCHEMBL9786201 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E
SCHEMBL10445274 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E
SCHEMBL10445275 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E
SCHEMBL2111943 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E
SCHEMBL1404382 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E
SCHEMBL16050848 1.00 ALDH1A1 (0.59) ALDH1A1TSHRFASNFAAHKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240616-A1 NOVEL LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (NO) 2010-09-23 US disclosed
EP-2129646-A2 OMEGA-3 LIPID COMPOUNDS Pronova Biopharma Norge AS (NO) 2009-12-09 EP disclosed
WO-2008132552-A2 OMEGA-3 LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (US) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240616-A1 NOVEL LIPID COMPOUNDS ELOVL3, FFAR3, STARD3 ALDH1A1 2317/4885TSHR 1431/4885FASN 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.